ArticlePDF Available

Clinical trials landscape in lower middle-income country (Pakistan) – CORRIGENDUM

Authors:
Hassan Mumtaz at BPP University
Hassan Mumtaz
Syed Muhammad Ali Haider at HITEC Institute of Medical Sciences
Syed Muhammad Ali Haider
  • HITEC Institute of Medical Sciences
Fnu Neha
Fnu Neha
Fnu Neha
  • This person is not on ResearchGate, or hasn't claimed this research yet.
Muhammad Saqib
Muhammad Saqib
Muhammad Saqib
  • This person is not on ResearchGate, or hasn't claimed this research yet.
Show all 7 authorsHide
Download full-text PDF
Read full-text
Download citation
Available via license: CC BY 4.0
Content may be subject to copyright.
Journal of Clinical and
Translational Science
www.cambridge.org/cts
Corrigendum
Cite this article: Mumtaz H, Haider SMA,
Neha F, Saqib M, Nadeem A, Fahim A, and
Allahuddin Z. Clinical trials landscape in lower
middle-income country (Pakistan) –
CORRIGENDUM. Journal of Clinical and
Translational Science 8: e35, 1. doi: 10.1017/
cts.2024.22
© The Author(s), 2024. Published by Cambridge
University Press on behalf of Association for
Clinical and Translational Science. This is an
Open Access article, distributed under the
terms of the Creative Commons Attribution
licence (https://creativecommons.org/licenses/
by/4.0/), which permits unrestricted re-use,
distribution, and reproduction in any medium,
provided the original work is properly cited.
Clinical trials landscape in lower middle-income
country (Pakistan) –CORRIGENDUM
Hassan Mumtaz, Syed Muhammad Ali Haider, Fnu Neha, Muhammad Saqib ,
Abdullah Nadeem, Ammad Fahim and Zoha Allahuddin
DOI: https://doi.org/10.1017/cts.2023.701, Published online by Cambridge University Press:
10 January 2024.
The above review published with mistakes in some author names and affiliations. One author
name was not included in the author list at all.
Hassan Mumtaz1,2, Syed Muhammad Ali Haider3, Fnu Neha4, Muhammad Saqib5,
Abdullah Nadeem6, Ammad Fahim7and Zoha Allahuddin6
1Clinical Research Associate, Maroof International Hospital, Islamabad, Pakistan; 2Public
Health Scholar, Health Services Academy, Islamabad, Pakistan; 3BMY Health, Lahore, Pakistan;
4Ghulam Muhammad Mahar Medical College, Sukkur, Pakistan; 5Khyber Medical College,
Peshawar, Pakistan and 6Dow University of Health Sciences, Karachi, Pakistan 7Director
Research, Maroof International Hospital Islamabad, Pakistan
The original review has been corrected online to rectify these errors.
See below for the authorship contribution statement, not included in the original review.
H.M.: Conceptualization, methodology, investigation, data curation, writing - original draft
preparation, visualization, and supervision.
S.M.A.H.: Writing - original draft preparation, data curation, and methodology.
F.N.: Writing - review and editing, data curation, visualization, and methodology.
M.S.: Investigation, data analysis, writing - original draft preparation, visualization.
A.N.: Writing - review and editing, proofreading, methodology, and investigation.
A.F.: Conceptualization, methodology, data curation, writing - review and editing.
Z.A.: Writing - review and editing, data curation, and investigation.
Reference
Mumtaz H, Haider SMA, Neha F, Saqib M, Nadeem A, Fahim A, Allahuddin Z. Clinical trials landscape
in a lower-middle-income country (Pakistan). Journal of Clinical and Translational Science. 2024;8(1):e7.
doi: 10.1017/cts.2023.701
https://doi.org/10.1017/cts.2024.22 Published online by Cambridge University Press
... Resource constraints, underdeveloped research infrastructure, and insufficient training programs leave many clinicians unprepared to engage with research critically (8,9). Ethical and regulatory barriers further complicate the integration of clinical research into practice, with prolonged approval processes and inconsistent implementation of research protocols (8,10). Moreover, institutional silos discourage collaboration between academia, healthcare facilities, and industry, slowing the adaptation of evidence-based advancements (4,5,11). ...
... To overcome these challenges, Pakistan must prioritize investment in healthcare research, establish specialized training programs, and create structured pathways for clinicians to engage in research (8)(9)(10)12). Stronger government-academic-private sector collaboration is necessary to bridge the gap between scientific discovery and clinical application. ...
View
Clinical trials landscape in a lower-middle-income country (Pakistan)
Article
Full-text available
  • Jan 2024
In recent times, there have been calls from within the developing nations for increased ownership by governmental research bodies and universities of the priority research setting and research that aligns with national health strategies. This is a review paper of the studies that have been published on clinical trials in developing countries, with a focus mainly on Pakistan. The literature review used online databases such as PubMed, Scopus, and Google Scholar, World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP), and ClinicalTrials.gov trial registries to search for clinical trials conducted in Pakistan between January 2000 and December 2022 and analyzed. The results revealed that clinical research in Pakistan is hindered by a number of barriers, including a lack of funding, skilled personnel, and regulatory issues. Lack of funding is a common obstacle, and the majority of funding for clinical trials originates from Western countries or pharmaceutical companies established in the West. In conclusion, clinical studies in developing countries, especially in Pakistan, are hindered by a plethora of barriers, and to improve the current state, increasing funding, streamlining ethical approval procedures, simplifying regulatory systems, addressing cultural and religious concerns, and participating in global efforts to bridge the gap in health-based research are crucial.
View